Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical, Biological and Histological Characteristics of Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy: A National Retrospective Cohort Study

NCT04641884 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04641884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04641884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical, Biological and Histological Characteristics of Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy: A National Retrospective Cohort Study
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2020
Completion date
April 1, 2021
Enrollment
85 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid, immunotherapy, programmed cell death ligand 1